Cargando. Por Favor Espere...


Avoid unnecessary biopsy

SelectMDx

A noninvasive urine test to detect the risk of developing Aggressive Prostate Cancer.





SelectMDx helps prevent unnecessary biopsies.

SelectMDx

Provides informed information to make a decision.

With a simple urine test it allows to improve the selection of patients who would benefit from a biopsy, and helps evade it in cases where it is unnecessary.
Based on the mRNA identification of the DLX1 and HOXC6 genes, it is possible to distinguish which patients are at increased risk of clinically significant cancer from those who do not.
Providing a negative predictive value of 99.6% for Gleason Score equal to or greater than 8 and 98% for GS equal to or greater than 7, this means that when this test determines that the risk for an aggressive cancer is low it has a very small margin Of error.

Possible results

1- MEN WITH HIGH RISK can benefit from biopsy and early detection.
2- MEN WITH VERY LOW RISK can avoid having to undergo unnecessary invasive procedures with routine follow-ups and screenings.

http://southgenetics.com/wp-content/uploads/2017/04/MDx627_SelectMDx_ForProstate_Logo-white.png

It can help determine if you need a biopsy.

If you have a high prostate-specific antigen (PSA) test result, you may be at risk for prostate cancer.


Helps prevent unnecessary biopsies.

SelectMDx


Provides informed information to make a decision. Ask your doctor about this test.

Want to know more about the SelectMDx Test?

KNOW MORE ABOUT THIS TEST IN YOUR COUNTRY

High PSA

However, the cause of elevated or increasing PSA may be related to benign (non-cancerous) conditions such as prostatitis or benign prostatic hyperplasia (BPH).


Consequences of a biopsy

Unfortunately, the biopsy procedure is invasive and can lead to complications. Common complications of a prostate biopsy may include bleeding, infection, sepsis / bacteremia, retention / urinary symptoms, and sexual dysfunction.

  • 18% of men suffer complications
  • About 3% are hospitalized for an infection within 30 days of the biopsy.
http://southgenetics.com/wp-content/uploads/2017/04/mdx_post.jpg

SouthGenetics

SouthGenetics es una empresa líder en el área de la comercialización de servicios de biotecnología. Nuestra misión es proveer a médicos y pacientes un rápido acceso a los servicios de diagnósticos genómicos de alta complejidad. A través de acuerdos estratégicos con los principales laboratorios del mundo en cada área brindamos servicios diagnósticos con foco en oncogenómica y en desórdenes cromosómicos.

Twitter

@SouthGeneticsLA - 1 year

SouthGenetics felicita a sus socios estratégicos, reconocidos por MIT Technology Review

@SouthGeneticsLA - 1 year

Trabajadores tendrán licencia para hacerse examen de próstata. Ph. Javier Calvelo adhoc Foto…

Contáctenos / Contact Us

Nuestro equipo está a su disposición para atender a todas sus consultas y/o sugerencias. Será un gusto poder comunicarnos con usted. No dude en ponerse en contacto.
Puede completar el formulario de contacto o comunicarse con el país de su preferencia.

Email: info@southgenetics.com

SouthGenetics - Todos los Derechos Reservados